KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
KBIO was delisted on the 16th of December, 2015.
19 hedge funds and large institutions have $3.36M invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
16% less capital invested
Capital invested by funds: $4.01M → $3.36M (-$651K)
21% less funds holding
Funds holding: 24 → 19 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$114K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.5K |
| 3 |
OWIM
Old West Investment Management
Los Angeles,
California
|
+$4.71K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$569K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$64K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
| 4 |
Millennium Management
New York
|
-$30K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$21K |
KBIO Hedge Fund Activity: Q2 2015 in Review
19 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q2 2015, worth a combined $3.36M — down 16% from $4.01M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of KBIO and 2 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $114K. The largest seller was BVF Inc, exiting entirely with an estimated $569K sold.
- 19 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q2 2015, down from 24 in Q1 2015.
- Funds reported $3.36M of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q2 2015, down 16% quarter-over-quarter.
- 2 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q2 2015 and 7 closed out, a net change of -5 holders.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) buyer in Q2 2015 was Renaissance Technologies, an estimated $114K added.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) seller in Q2 2015 was BVF Inc, an estimated $569K sold.
Based on aggregated 13F filings for Q2 2015.